Cargando…
Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments
The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) created Medicare Part D, a voluntary prescription drug benefit program. The benefit is a government subsidized prescription drug benefit within Medicare. This article focuses on the development of the prescription drug ris...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
CENTERS for MEDICARE & MEDICAID SERVICES
2007
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195001/ https://www.ncbi.nlm.nih.gov/pubmed/17722748 |
| _version_ | 1782339233533394944 |
|---|---|
| author | Robst, John Levy, Jesse M. Ingber, Melvin J. |
| author_facet | Robst, John Levy, Jesse M. Ingber, Melvin J. |
| author_sort | Robst, John |
| collection | PubMed |
| description | The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) created Medicare Part D, a voluntary prescription drug benefit program. The benefit is a government subsidized prescription drug benefit within Medicare. This article focuses on the development of the prescription drug risk-adjustment model used to adjust payments to reflect the health status of plan enrollees. |
| format | Online Article Text |
| id | pubmed-4195001 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2007 |
| publisher | CENTERS for MEDICARE & MEDICAID SERVICES |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-41950012014-11-04 Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments Robst, John Levy, Jesse M. Ingber, Melvin J. Health Care Financ Rev Research Article The 2003 Medicare Prescription Drug, Improvement, and Modernization Act (MMA) created Medicare Part D, a voluntary prescription drug benefit program. The benefit is a government subsidized prescription drug benefit within Medicare. This article focuses on the development of the prescription drug risk-adjustment model used to adjust payments to reflect the health status of plan enrollees. CENTERS for MEDICARE & MEDICAID SERVICES 2007 /pmc/articles/PMC4195001/ /pubmed/17722748 Text en |
| spellingShingle | Research Article Robst, John Levy, Jesse M. Ingber, Melvin J. Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments |
| title | Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments |
| title_full | Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments |
| title_fullStr | Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments |
| title_full_unstemmed | Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments |
| title_short | Diagnosis-Based Risk Adjustment for Medicare Prescription Drug Plan Payments |
| title_sort | diagnosis-based risk adjustment for medicare prescription drug plan payments |
| topic | Research Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4195001/ https://www.ncbi.nlm.nih.gov/pubmed/17722748 |
| work_keys_str_mv | AT robstjohn diagnosisbasedriskadjustmentformedicareprescriptiondrugplanpayments AT levyjessem diagnosisbasedriskadjustmentformedicareprescriptiondrugplanpayments AT ingbermelvinj diagnosisbasedriskadjustmentformedicareprescriptiondrugplanpayments |